NFKBIA and nasopharyngeal carcinoma: Importantly, by impeding the activation of p38 MAPK via its pharmacological inhibitor, it also suppressed the resistin-mediated activation of NF-κB in the NPC cells (Figure 6A,C) and reversed the resistin-induced phosphorylation of IκBα (Figure 6D,E).